Gestamp Automocin (Germany) Performance
| 7GA Stock | 2.53 0.08 3.07% |
The company retains a Market Volatility (i.e., Beta) of -0.22, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Gestamp Automocin are expected to decrease at a much lower rate. During the bear market, Gestamp Automocin is likely to outperform the market. Gestamp Automocin right now retains a risk of 2.28%. Please check out Gestamp Automocin skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Gestamp Automocin will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Gestamp Automocin SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Gestamp Automocin is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Free Cash Flow | 213.9 M |
Gestamp |
Gestamp Automocin Relative Risk vs. Return Landscape
If you would invest 255.00 in Gestamp Automocin SA on September 2, 2024 and sell it today you would lose (2.00) from holding Gestamp Automocin SA or give up 0.78% of portfolio value over 90 days. Gestamp Automocin SA is generating 0.0133% of daily returns and assumes 2.2804% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Gestamp, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Gestamp Automocin Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gestamp Automocin's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Gestamp Automocin SA, and traders can use it to determine the average amount a Gestamp Automocin's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0058
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 7GA |
Estimated Market Risk
| 2.28 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gestamp Automocin is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gestamp Automocin by adding Gestamp Automocin to a well-diversified portfolio.
Gestamp Automocin Fundamentals Growth
Gestamp Stock prices reflect investors' perceptions of the future prospects and financial health of Gestamp Automocin, and Gestamp Automocin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gestamp Stock performance.
| Current Valuation | 3.43 B | |||
| Price To Book | 0.89 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 8.09 B | |||
| EBITDA | 1.01 B | |||
| Total Debt | 2.65 B | |||
| Cash Flow From Operations | 827.39 M | |||
| Total Asset | 8.64 B | |||
About Gestamp Automocin Performance
Assessing Gestamp Automocin's fundamental ratios provides investors with valuable insights into Gestamp Automocin's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Gestamp Automocin is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Gestamp Automocin performance evaluation
Checking the ongoing alerts about Gestamp Automocin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gestamp Automocin help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Gestamp Automocin's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Gestamp Automocin's stock performance include:- Analyzing Gestamp Automocin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gestamp Automocin's stock is overvalued or undervalued compared to its peers.
- Examining Gestamp Automocin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gestamp Automocin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gestamp Automocin's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gestamp Automocin's stock. These opinions can provide insight into Gestamp Automocin's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Gestamp Stock Analysis
When running Gestamp Automocin's price analysis, check to measure Gestamp Automocin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gestamp Automocin is operating at the current time. Most of Gestamp Automocin's value examination focuses on studying past and present price action to predict the probability of Gestamp Automocin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gestamp Automocin's price. Additionally, you may evaluate how the addition of Gestamp Automocin to your portfolios can decrease your overall portfolio volatility.